Patient info Open main menu

Qvar 100 inhaler – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
100 microgram/dose
Contains active substance:

Patient leaflet - Qvar 100 inhaler

1. WHAT QVAR INHALER IS AND WHAT IT IS USED FOR

Qvar Inhaler contains beclometasone dipropionate, which is one of a group of medicines known as corticosteroids.

Qvar Inhaler is used to prevent the symptoms of mild, moderate, or severe asthma, in patients who require regular treatment.

How your medicine works

  • Qvar Inhaler works deep in your lungs to make breathing easier by reducing the inflammation, swelling and irritation in the airways. This type of medicine is known as a ‘preventer’. It needs to be taken regularly every day, even if you have no symptoms.
  • This inhaler will not give immediate relief of wheezing or breathlessness during a sudden asthma attack. You will need to use a ‘reliever’ inhaler, which contains a different medicine. You should still continue to use this inhaler.

2. WHAT YOU NEED TO KNOW BEFORE YOU USE QVAR INHALER

Do not use Qvar Inhaler:

  • if you are allergic to beclometasone dipropionate or any of the other ingredients of this medicine (listed in section 6).
  • if you are allergic to other similar inhalers.
  • if you are suffering from a sudden attack of breathlessness. It will not help. Use a quick-acting ‘reliever’ inhaler for this purpose and carry it with you at all times.

    PATIENT INFORMATION LEAFLET

    Qvar 100 Inhaler

    (beclometasone dipropionate)

Other medicines and Qvar Inhaler

  • Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including any medicines obtained without a prescription.

In particular tell your doctor if you are taking:

  • Disulfiram
  • Metronidazole

Some medicines may increase the effects of Qvar Inhaler and your doctor may wish to monitor you carefully if you are taking these medicines (including some medicines for HIV: ritonavir, cobicistat).

Pregnancy, breast-feeding and fertility

  • If you are pregnant, planning to become pregnant or are breast-feeding, ask your doctor for advice before taking this medicine.

Driving and using machines

  • Qvar Inhaler is not known to affect your ability to drive or operate machinery.

Important information about some of the ingredients of Qvar Inhaler:

Qvar Inhaler contains a small amount of alcohol. Talk to your doctor if you need to avoid alcohol for any reason.

This medicine contains 4.74 mg of alcohol (ethanol) in each puff. The amount in one puff of this medicine is equivalent to less than 1ml beer or 1 ml wine. The small amount of alcohol in this medicine will not have any noticeable effects.

3. HOW TO USE QVAR INHALER

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

There are two strengths of Qvar Inhaler available and your doctor will have chosen the strength which best suits your condition.

This inhaler has a softer feel and a different taste than other inhalers you may have used before. This inhaler is an extra fine inhaler which results in more of each dose being delivered to your lungs. Your doctor may, therefore, prescribe a lower dose of this inhaler than your previously used inhaler.

Even when your doctor has prescribed a lower dose you may find that the number of puffs you are asked to take from this inhaler is the same as from your previous inhaler; this is because this inhaler may be a lower strength product (which means that each puff of this inhaler contains less beclometasone dipropionate than your old inhaler).

Do not take more puffs than your doctor has told you to. In some circumstances, your doctor may prescribe more than the usual number of puffs. The usual number of puffs to take is:

If you forget to use Qvar Inhaler

If you forget to use this inhaler at your usual time, take your recommended number of puffs as soon as you remember unless it is nearly time to use your inhaler again. DO NOT take a double dose to make up for a forgotten dose.

Then continue to use your inhaler regularly at the correct time, as prescribed by your doctor.

If you stop using Qvar Inhaler

This inhaler must be used regularly, even when you feel well. You must not stop using your inhaler unless your doctor tells you to.

Ask your doctor for a prescription for a replacement inhaler before this one is empty. If your doctor decides to stop treatment, return the inhaler to your doctor or pharmacist for safe disposal.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Using your Qvar Inhaler

Before Use

  • If this is a new inhaler or if you have not used your inhaler for two weeks or more, it must be tested before use by removing the mouthpiece cover and pressing down on the canister inside the inhaler.

    Release 2 puffs into the air, away from you.

How to use your inhaler

  1. 1.

    Take the cover off the

    mouthpiece.

  2. 2.

    Breathe out as far as is

    comfortable and then

    immediately place the

    mouthpiece in your mouth

    and close your lips around it.

  3. 3.

    Start to breathe in slowly

    and deeply through

    your mouth and press down

    on the canister inside the

    inhaler as shown. This

    releases one puff of

    medicine. It is important that

    you carry on breathing in

    after the puff is released.

  4. 4.

    Hold your breath for 10

    seconds, then breathe out

    slowly. If your doctor has

    prescribed more than

    one puff repeat steps 2 to 4

    again. After use, replace the

    cover on the mouthpiece.

Qvar 50 Inhaler

Adults (including the elderly) and adolescents over 12 years

  • Mild Asthma

The starting dose is one puff twice a day. This may be increased up to two puffs twice a day.

  • Moderate Asthma

The starting dose is two puffs twice a day. This may be increased up to four puffs twice a day.

  • Severe Asthma

The starting dose is four puffs twice a day. This may be increased up to eight puffs twice a day.

The maximum dose is a total of sixteen puffs a day.

Qvar 100 Inhaler

Adults (including the elderly) and adolescents over 12 years

  • Mild Asthma

The Qvar 100 Inhaler device is not suitable for the starting dose. It is suitable for an increased dose of one puff twice a day.

  • Moderate Asthma

The starting dose is one puff twice a day. This may be increased to two puffs twice a day.

  • Severe Asthma

The starting dose is two puffs twice a day. This may be increased up to four puffs twice a day.

The maximum dose is a total of eight puffs a day.

Children aged 5 years and over

The starting dose is one puff of Qvar 50 Inhaler twice a day.

Children with well-controlled asthma on doses of up to 400 micrograms per day of other beclometasone dipropionate inhalers or equivalent may be titrated to a dose of 50-100 micrograms twice daily of Qvar.

Qvar 100 Inhaler would not normally be recommended in this age group. However, during periods of deterioration in asthma control, the dose may be increased to 200 micrograms per day in two divided doses. The dose should be reduced to the minimum needed to maintain effective control of asthma.

What to do if you think your treatment is not working

If you think your usual treatment is not working, for example your symptoms are not getting better, or are getting worse, or you need to use more puffs from your reliever inhaler, or if your reliever inhaler does not seem to be working as well as usual, or your peak flow falls, please tell your doctor. Your asthma may be getting worse.

If you use more Qvar Inhaler than you should

It is important that you take your dose as stated on the pharmacist’s label, or as advised by your doctor. You should not increase or decrease your dose without seeking medical advice. If you accidentally take more puffs than recommended, please tell your doctor.

  • Some people including children and the elderly find it difficult to press their inhaler and breathe in at the same time.

    A spacer device helps to overcome this problem. The spacer that fits Qvar Inhaler is called the AeroChamber Plus® spacer device. If you use the AeroChamber Plus® spacer device, please follow the instructions provided with it. Your doctor, nurse or pharmacist will be able to advise you about the AeroChamber Plus® device. Alternatively your doctor may wish to prescribe the Qvar Autohaler® device which automatically releases a puff of medication as you breathe in.

How to tell when your Qvar Inhaler device is empty

When the canister is completely empty you will not feel or hear any propellant being discharged.

Cleaning instructions

For normal hygiene, the mouthpiece of your inhaler should be cleaned weekly with a clean, dry tissue or cloth. You should also rinse your mouth with water after using your inhaler.

Do not wash or put any part of your inhaler in water

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. If immediately after taking a puff of this inhaler, you feel wheezy or tight chested do not take any more puffs. Use your reliever inhaler to help your breathing and contact your doctor immediately.

Stop using your inhaler and tell your doctor immediately or go to the casualty department at your nearest hospital if the following happens:

  • an allergic reaction (swelling of the lips, face or neck leading to severe difficulty in breathing; skin rash or hives).

This is a very serious but rare side effect. You may need urgent medical attention or hospitalisation. Treatment with Qvar Inhaler may affect the normal production of corticosteroids in the body, your doctor may take a blood sample from time to time to check on this.

Keep using your inhaler but see your doctor as soon as possible if you become unwell, particularly with any of the following:

  • abdominal pain
  • weakness
  • vomiting

This is especially important if you have been exposed to other stress such as other illness, surgery, or infection.

The following side effects may also occur in patients taking beclometasone dipropionate. If you experience any of these effects, keep using your inhaler but see your doctor if they last for a while or they are worrying you:

Ref: 0718/050126/1/B Qvar Inhaler contains ethanol

Common (may affect up to 1 in 10 people):

  • hoarseness
  • difficulty in swallowing accompanied by earache and swollen glands, sore throat (pharyngitis)
  • a sore mouth or thrush (white spots in your mouth and throat). These are less likely if you rinse your mouth out with water after using your inhaler. If you get thrush your doctor may recommend a medicine to treat you
  • change in taste

Uncommon (may affect up to 1 in 100 people):

  • feeling sick
  • headache
  • tremor (shaking)
  • feeling dizzy or faint
  • difficulty in breathing, increase in wheezing, shortness of breath and cough (bronchospasm)
  • blurred vision

Very rare (may affect up to 1 in 10,000 people):

  • bone thinning
  • clouding of the lens of the eye (cataract) resulting in blurred vision
  • loss of vision due to abnormally high pressure in the eye may occur

The following may also occur, although the frequency is not known (cannot be estimated from the available data):

  • sleeping problems, depression or feeling worried, restless, nervous, over-excited or irritable. These effects are more likely to occur in children

Children or adolescents who are using the inhaler for a prolonged period may grow more slowly. Your doctor may therefore wish to monitor the height of a child receiving prolonged treatment with Qvar Inhaler.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE QVAR INHALER

  • KEEP OUT OF THE SIGHT AND REACH OF CHILDREN.
  • Do not store above 25°C.
  • Do not expose to temperatures above 50°C.
  • Do not spray on an open flame or other source of ignition.
  • Avoid storage in direct sunlight or heat.
  • Protect from frost.
  • Do not use this medicine after the expiry date that is stated on the outer packaging after EXP. The expiry date refers to the last day of that month.
  • The canister is pressurised and should not be punctured or burnt even if it seems empty.
  • If your medicine shows any other signs of deterioration, consult your pharmacist (chemist) who will tell you what to do.

Medicines should not be disposed of via wastewater or household waste. If your doctor decides to stop treatment, return the inhaler to your doctor or pharmacist for safe disposal. These measures will help to protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION

Your Qvar Inhaler does not contain CFCs; instead, the inhaler contains a hydrofluoroalkane (called propellant HFA- 134a or norflurane) as an inactive ingredient. Hydrofluoroalkanes have been developed as a replacement for CFCs. What Qvar Inhaler contains:

  • The active ingredient is beclometasone dipropionate.

    The Qvar 100 Inhaler delivers 100 micrograms of beclometasone dipropionate per puff.

  • The other ingredients are HFA-134a (norflurane) and ethanol.
  • This medicine contains fluorinated greenhouse gases.

Container with 200 puffs:

  • Each inhaler contains 13.13 g of norflurane (HFA-134a) corresponding to 0.01878 tonne CO2 equivalent (global warming potential GWP = 1430).

What Qvar Inhaler looks like and contents of the pack:

  • Qvar Inhaler is a grey and dark-red multi dose inhaler device enclosing a pressurised canister and fitted with a metering valve and inhaler actuator.
  • Qvar Inhaler contains 200 Actuations.

Manufacturer and Licence Holder

Manufactured by Norton (Waterford) Limited, T/A Teva Pharmaceuticals Ireland, Unit 27/35 IDA Industrial Park, Cork Road, Waterford, Ireland and is procured from within the EU and repackaged by the Product Licence Holder: Lexon (UK) Limited, Unit 18, Oxleasow Road, East Moons Moat, Redditch, Worcestershire, B98 0RE.

If you have any questions or are not sure about anything, ask your doctor or pharmacist. They will have additional information about this medicine and will be able to advise you.

PL 15184/0718 - Qvar 100 Inhaler Qvar is a registered trademark of Teva Pharmaceuticals International GmbH. AeroChamber is a registered trademark of Trudell Medical International.

Leaflet revision date: 05/01/2026

Blind or partially sighted? Is this leaflet hard to see or read? Phone Lexon (UK) Limited,

Tel: 01527 505414 to obtain the leaflet in a format suitable for you

®

Ref: 0718/050126/1/F

POM

For further information about asthma, contact Asthma UK, the independent UK charity working to conquer asthma: Asthma UK, Summit House, 70 Wilson Street, London, EC2A 2DB. Asthma Helpline: 0845 7 010203 (Open Monday to Friday, 9am to 5pm, calls charged at local rates).

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLPI 15184/0718

Last revision stated in the text: 5 January 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Qvar 100 inhaler

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Beclometasone
Strength 100 microgram/dose
Pharmaceutical form Pressurised inhalation
How is it taken Inhalation
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. R Respiratory system drugs
    1. R03 Drugs for obstructive airway diseases
      1. R03B Other drugs for obstructive airway diseases, inhalants
        1. R03BA Glucocorticoid inhalants for obstructive airway disease
          1. R03BA01 beclometasone
Marketing authorisation PLPI 15184/0718
Codes BNF 03020000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.